Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital
Launched by IRCCS SAN RAFFAELE · Jun 25, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital, is focused on understanding and managing low vitamin D levels, known as hypovitaminosis D. The hospital aims to gather information from 1,000 adult patients who are starting vitamin D supplementation. This registry will collect data over ten years, helping researchers learn about how common low vitamin D levels are, what might cause them, and how best to treat them.
To be eligible for this study, you must be an adult (18 years or older) and currently taking vitamin D supplements, no matter the type or amount. You’ll need to give your consent to participate. If you join the study, you can expect to have your health information collected during your visits to the hospital, which will help doctors improve their understanding and treatment of vitamin D deficiency. This research will continue until December 2029, and the findings could greatly benefit future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult men and women (age ≥ 18 years) regardless of fertility status and pregnancy/breastfeeding conditions
- • Vitamin D supplementation, with any formulation and dosage
- • Signing of informed consent
- Exclusion Criteria:
- • Patients unable to understand and sign informed consent.
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported